By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Celtaxsys, Inc. 

ATDC Biosciences Center
311 Ferst Drive
Atlanta  Georgia  30332  U.S.A.
Phone: 404-920-0700 Fax: 404-920-0701


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Celtaxsys, Inc. Initiates First Clinical Trial of Oral CTX-4430 Therapy in Cystic Fibrosis Patients 10/11/2013 9:02:03 AM
Celtaxsys, Inc. Announces Successful Completion of Phase 1 Clinical Trial for Development of CTX-4430 9/17/2013 8:30:32 AM
Celtaxsys, Inc. Restructures Management and Operations; CEO, CTO Out 9/10/2013 7:15:22 AM
Celtaxsys, Inc. Appoints Khalil Barrage to Board of Directors 4/19/2013 7:46:33 AM
Celtaxsys, Inc. Initiates Phase 1 Study of CTX-4430 Oral Treatment for Pulmonary Inflammation 1/3/2013 9:49:44 AM
Brett Premack, Ph.D. Joins Celtaxsys, Inc. as Chief Technology Officer 10/24/2012 8:50:19 AM
Celtaxsys, Inc. Acquires Clinical Stage Innate Immunity Drug for Inflammation 1/5/2012 3:01:59 PM
Dr. H. Daniel Perez Joins Celtaxsys, Inc. Board of Directors 6/6/2011 1:25:00 PM
Dr. Michael Hanley Joins Celtaxsys, Inc. as CEO 12/3/2010 7:09:34 AM
Celtaxsys, Inc. Seeks $10 Million to Develop Immune System Drugs; Raises $4.2 Million So Far 11/5/2010 6:54:10 AM
12
//-->